[go: up one dir, main page]

PE20020193A1 - Pirroloquinolonas como agentes antivirales - Google Patents

Pirroloquinolonas como agentes antivirales

Info

Publication number
PE20020193A1
PE20020193A1 PE2001000659A PE2001000659A PE20020193A1 PE 20020193 A1 PE20020193 A1 PE 20020193A1 PE 2001000659 A PE2001000659 A PE 2001000659A PE 2001000659 A PE2001000659 A PE 2001000659A PE 20020193 A1 PE20020193 A1 PE 20020193A1
Authority
PE
Peru
Prior art keywords
cycloalkyl
aryl
alkyl
pyroloquinolones
halogen
Prior art date
Application number
PE2001000659A
Other languages
English (en)
Inventor
Valerie A Vaillancourt
Sandra Staley
Audris Huang
Richard A Nugent
Ke Chen
Sajiv K Nair
James A Nieman
Joseph W Strohbach
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PE20020193A1 publication Critical patent/PE20020193A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/582Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE REFIERE A PIRROLOQUINOLONAS DONDE R1 ES F, Cl, Br, CN, NO2: R2 Y R3 SON H, HALOGENO, OR11, COR7, COOR11, CICLOALQUILO C3-C8, ALQUILO C1-C7; R4 Y R5 SON H, HALOGENO, ARILO, SOmR7, COR7, ENTRE OTROS; R6 ES H, HALOGENO, CICLOALQUILO C3-C8, ALQUILO C1-C4; R7 ES ALQUILO C1-C7, CICLOALQUILO C3-C5, NR8R9, ARILO, HETEROCICLO; R8 Y R9 SON H, ARILO, CICLOALQUILO C3-C8; R11 ES H, CICLOALQUILO C3-C8, ALQUILO C1-C7, ARILO. SON COMPUESTOS PREFERIDOS N-(4-CLOROBENCIL)-2-(2-HIDROXIETIL)-6-OXO-8-(TETRAHIDRO-2H-PIRAN-4-ILMETIL)-6H-PIRROLO[3,2,1-ij]QUINOLEINA-5-CARBOXAMIDA; N-(4-CLOROBENCIL)-2-(HIDROXIMETIL)-8-(4-MORFOLINILMETIL)-6-OXO-6H-PIRROLO[3,2,1-ij]QUINOLEINA-5-CARBOXAMIDA. LOS COMPUESTOS SON INHIBIDORES DE ADN POLIMERASA UTILES COMO AGENTES ANTIVIRALES
PE2001000659A 2000-07-05 2001-07-03 Pirroloquinolonas como agentes antivirales PE20020193A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21598600P 2000-07-05 2000-07-05
US27701201P 2001-03-19 2001-03-19

Publications (1)

Publication Number Publication Date
PE20020193A1 true PE20020193A1 (es) 2002-03-02

Family

ID=26910543

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000659A PE20020193A1 (es) 2000-07-05 2001-07-03 Pirroloquinolonas como agentes antivirales

Country Status (14)

Country Link
US (2) US6525049B2 (es)
EP (1) EP1299386A1 (es)
JP (1) JP2004502689A (es)
KR (1) KR20030014320A (es)
CN (1) CN1437600A (es)
AR (1) AR031857A1 (es)
AU (1) AU2001271258A1 (es)
CA (1) CA2410658A1 (es)
MX (1) MXPA03000107A (es)
MY (1) MY117789A (es)
NZ (1) NZ523449A (es)
PE (1) PE20020193A1 (es)
TW (1) TW593316B (es)
WO (1) WO2002002558A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004019939A1 (en) * 2002-08-30 2004-03-11 Pharmacia & Upjohn Company Method of preventing or treating atherosclerosis or restenosis
ATE433974T1 (de) 2003-09-19 2009-07-15 Gilead Sciences Inc Azachinolinolphosphonatverbindungen als integraseinhibitoren
ES2315922T3 (es) * 2004-04-14 2009-04-01 Gilead Sciences, Inc. Analogos de fosfonato de compuestos inhibidores de la integrasa del vih.
DE102006005861A1 (de) * 2006-02-09 2007-08-23 Aicuris Gmbh & Co. Kg Substituierte Chinolone III
AU2008240764C1 (en) * 2007-04-20 2011-10-20 Glaxo Group Limited Tricyclic nitrogen containing compounds as antibacterial agents
WO2014062655A1 (en) 2012-10-16 2014-04-24 Janssen Pharmaceutica Nv HETEROARYL LINKED QUINOLINYL MODULATORS OF RORyt
ES2628365T3 (es) 2012-10-16 2017-08-02 Janssen Pharmaceutica N.V. Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T
SG11201502369XA (en) 2012-10-16 2015-05-28 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of ror-gamma-t
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
KR20160070133A (ko) 2013-10-15 2016-06-17 얀센 파마슈티카 엔.브이. RORyt의 알킬 결합 퀴놀리닐 조절제
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
KR20160068956A (ko) 2013-10-15 2016-06-15 얀센 파마슈티카 엔.브이. RORyT의 퀴놀리닐 조절제
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US11072610B2 (en) 2018-09-12 2021-07-27 Novartis Ag Antiviral pyridopyrazinedione compounds
CN120842223A (zh) 2019-09-26 2025-10-28 诺华股份有限公司 抗病毒吡唑并吡啶酮化合物
CN111349094B (zh) * 2020-04-23 2021-02-02 杭州师范大学 一种6H-咪唑[4,5,1-ij]并喹诺酮及其合成方法和应用
CN112349961B (zh) * 2020-11-12 2021-09-24 宁德新能源科技有限公司 电解液及包含其的电化学装置和电子设备

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3917609A (en) 1973-06-27 1975-11-04 Minnesota Mining & Mfg Pyrroloquinoline carboxylic acids and derivatives
DE2914218C2 (de) 1978-04-12 1985-10-24 Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo N-Acylderivate des Ampicillins und Amoxicillins, Verfahren zu deren Herstellung und pharmazeutische Zubereitungen, welche die Verbindungen enthalten
JPS55145612A (en) 1979-05-02 1980-11-13 Otsuka Pharmaceut Co Ltd Anti-bacterial agent
JPS55153792A (en) 1979-05-18 1980-11-29 Otsuka Pharmaceut Co Ltd Cephalosporanic acid derivative
IE52670B1 (en) 1981-03-03 1988-01-20 Leo Ab Heterocyclic carboxamides,compositions containing such compounds,and processes for their preparation
JPH0262875A (ja) 1988-05-23 1990-03-02 Wakunaga Pharmaceut Co Ltd 新規イソインドリン誘導体
GB2236751B (en) 1989-10-14 1993-04-28 Wyeth John & Brother Ltd Heterocyclic compounds
GB9108547D0 (en) 1991-04-22 1991-06-05 Fujisawa Pharmaceutical Co Quinoline derivatives
NZ290946A (en) 1994-08-12 1997-12-19 Toyama Chemical Co Ltd Quinolone- or naphthyridone-carboxylic acid derivatives
JP2000505451A (ja) 1996-02-21 2000-05-09 ダーウィン・ディスカバリー・リミテッド キノロン類およびこれらの治療的使用
US5792774A (en) * 1996-02-21 1998-08-11 Chiroscience Limited Quinolones and their therapeutic use
WO1997030999A1 (en) 1996-02-21 1997-08-28 Darwin Discovery Limited Quinolones and their therapeutic use
WO1999032450A1 (en) 1997-12-22 1999-07-01 Pharmacia & Upjohn Company 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
ITMI981670A1 (it) * 1998-07-21 2000-01-21 Zambon Spa Derivati ftalazinici inibitori della fosfodiesterasi 4
US6248739B1 (en) 1999-01-08 2001-06-19 Pharmacia & Upjohn Company Quinolinecarboxamides as antiviral agents

Also Published As

Publication number Publication date
TW593316B (en) 2004-06-21
KR20030014320A (ko) 2003-02-15
CA2410658A1 (en) 2002-01-10
US6525049B2 (en) 2003-02-25
AR031857A1 (es) 2003-10-08
AU2001271258A1 (en) 2002-01-14
MY117789A (en) 2004-08-30
EP1299386A1 (en) 2003-04-09
US6683181B2 (en) 2004-01-27
WO2002002558A1 (en) 2002-01-10
US20020055636A1 (en) 2002-05-09
JP2004502689A (ja) 2004-01-29
MXPA03000107A (es) 2003-08-19
NZ523449A (en) 2004-09-24
US20030153561A1 (en) 2003-08-14
CN1437600A (zh) 2003-08-20

Similar Documents

Publication Publication Date Title
PE20020193A1 (es) Pirroloquinolonas como agentes antivirales
PE20020143A1 (es) Carboxamidas heterociclicas como agentes antivirales
PE20040590A1 (es) Composiciones de pirrolotriazina anilina como inhibidores de cinasa
PE20020753A1 (es) Heteroaromaticos fusionados como activadores de la glucoquinasa
PE20010671A1 (es) Indolinonas sustituidas en posicion 6 como inhibidores de tirosina-quinasas
PE20010629A1 (es) Derivados de triazolpiridinamina como ligandos de receptores de adenosina
SV2002000195A (es) Compuestos farmaceuticamente activos ref. pcs10342 afae/bb
PE20020190A1 (es) Carboxamidas heterociclicas como agentes antivirales
AR017729A1 (es) Composicion y procedimientos para el tenido de las fibras queratinicas y en particular de las fibras queratinicas humanas tales como los cabellos y un dispositivo de varios compartimientos o kit de tenido de varios compartimientos.
PE20011089A1 (es) Tioamidas de oxazolidinona con sustituyentes de piperazin-amida
AR038401A1 (es) Derivados de indazol substituidos como agentes terapeuticos
EA199900693A1 (ru) Атропизомеры 3-арил-4(3h)-хиназолинонов и их использование в качестве антагонистов амра-рецепторов
PE20020470A1 (es) Derivados de pirazol como inhibidores de las enzimas proteina quinasas
HUP0300196A2 (hu) 2-Oxo-1-pirrolidin-származékok, eljárás előállításukra és alkalmazásuk
DE60226146D1 (de) Neue substituierte anilinderivate mit herbizider wirkung
AR038341A1 (es) Compuestos que son agonistas de receptores alfa-1 preferentemente agonistas de receptores alfa-1a/l
PE97799A1 (es) Derivados de piridina
CO5251410A1 (es) Derivados de nitrilo como inhibidores de la captesina k
AR026351A1 (es) Derivados de pirrol como inhibidores de la fosfodiesterasa vii
PE20020189A1 (es) Oxazinquinolonas utiles en el tratamiento de infecciones virales
ES2113081T3 (es) 1,4-benzotiazepinas utiles como agentes neurologicos.
ATE82573T1 (de) Aminoimidazochinolin-derivate.
PE20011349A1 (es) 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales
AR026352A1 (es) Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii.
PE20050587A1 (es) Derivados de diazindol-dicarbonilo-piperazinilo como agentes antivirales

Legal Events

Date Code Title Description
FX Voluntary withdrawal